Caricamento...
The safety and effectiveness of open-label extended-release carbamazepine in the treatment of children and adolescents with bipolar I disorder suffering from a manic or mixed episode
OBJECTIVE: To assess the safety and effectiveness of open-label treatment with extended-release carbamazepine (ERC) in pediatric subjects suffering from bipolar I disorder. METHOD: Medically healthy youths aged 10–17 years suffering from an acute manic or mixed episode were eligible. After screening...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4156006/ https://ncbi.nlm.nih.gov/pubmed/25210452 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S68951 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|